Catalyst Capital Advisors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-4,100
Closed -$781K 524
2018
Q3
$781K Buy
+4,100
New +$753K 0.03% 186
2017
Q4
Sell
-1,330
Closed -$273K 512
2017
Q3
$273K Buy
+1,330
New +$309K 0.01% 236
2017
Q1
Sell
-1,650
Closed -$347K 604
2016
Q4
$347K Buy
+1,650
New +$342K 0.02% 223
2016
Q3
Sell
-8,740
Closed -$2.02M 561
2016
Q2
$2.02M Sell
8,740
-1,100
-11% -$254K 0.37% 94
2016
Q1
$2.64M Sell
9,840
-6,800
-41% -$1.95M 0.44% 71
2015
Q4
$5.2M Buy
16,640
+1,880
+13% +$560K 0.75% 52
2015
Q3
$4.01M Buy
14,760
+6,500
+79% +$2M 0.54% 73
2015
Q2
$2.51M Sell
8,260
-1,288
-13% -$384K 0.29% 98
2015
Q1
$2.84M Buy
9,548
+1,288
+16% +$367K 0.33% 94
2014
Q4
$2.13M Hold
8,260
0.25% 92
2014
Q3
$1.99M Buy
8,260
+680
+9% +$152K 0.26% 91
2014
Q2
$1.69M Hold
7,580
0.28% 102
2014
Q1
$1.56M Hold
7,580
0.35% 100
2013
Q4
$1.27M Sell
7,580
-1,060
-12% -$166K 0.41% 92
2013
Q3
$1.24M Sell
8,640
-7,500
-46% -$999K 0.68% 36
2013
Q2
$2.04M Buy
+16,140
New +$1.83M 1.58% 2

Other funds holding AGN

Catalyst Capital Advisors's AGN Position: Q4 2018 in Review

Catalyst Capital Advisors sold out of Allergan plc (AGN) in Q4 2018, closing a stake of 4,100 shares — an estimated $781K sold.

Catalyst Capital Advisors first reported a position in AGN in Q2 2013 and held it in 16 quarters. The position peaked at $5.2M in Q4 2015. 1,007 funds tracked by Wall St. Rank hold AGN as of Q4 2018.

  • Catalyst Capital Advisors reported no remaining Allergan plc position as of Q4 2018 after selling out during the quarter.
  • Catalyst Capital Advisors sold 4,100 Allergan plc shares in Q4 2018, an estimated $781K.
  • Catalyst Capital Advisors first reported a position in Allergan plc in Q2 2013 and held it in 16 quarters.
  • Catalyst Capital Advisors's Allergan plc position peaked at $5.2M in Q4 2015.
  • 1,007 funds tracked by Wall St. Rank held Allergan plc as of Q4 2018.

Based on Catalyst Capital Advisors's 13F filing for Q4 2018, filed 7 Feb 2019.